Key result
Frailty was associated with a higher rate of cardiovascular death within one year after CABG compared to patients without frailty (3.8% vs 1.3%; OR 1.4; 95% CI 1.2-2.2; p=0.041).
Why the study?
To assess the role of frailty in complications and adverse outcomes after CABG in the early and long-term follow-up period using the diagnostic algorithm from Russian clinical guidelines on frailty.
Does frailty predict adverse outcomes in CAD patients undergoing CABG?
Cohort (n=387)
Does frailty predict adverse outcomes in CAD patients undergoing CABG?
Odds Ratio: 1.4 (95% CI 1.2–2.2)
Absolute Event Rate: 3.8% vs 1.3%
p-value: p=0.041
Frailty is a significant predictor of 1-year cardiovascular mortality in patients with CAD undergoing CABG.
May inform preoperative risk stratification in CABG; hypothesis-generating and requires prospective validation before practice change.
Objective. To assess the role of frailty in complications and adverse outcomes after coronary artery bypass grafting (CABG) in early and long-term follow-up period considering the diagnostic algorithm presented in the Russian clinical guidelines on frailty. Material and methods. The study included 387 coronary artery disease (CAD) patients admitted for CABG. A multistage algorithm including a questionnaire “Age is not a drawback”, short test battery for assessing physical functioning and brief cognitive screening test (Mini-Cog) was used to diagnose prefrailty and frailty in patients. Statistical analysis was carried out using the IBM SPSS Statistics software (ver. 26.0.0). Differences were significant at p<0.05. Results. The prevalence of frailty in CAD patients was 47%. There was 3 times lower number of patients with prefrailty (15%). Patients with prefrailty and frailty significantly more often had hypertension (p=0.001), smoking (p=0.008) and previous stroke (p=0.031). When analyzing the characteristics of intraoperative and early postoperative period after CABG, we found no significant differences in the incidence of complications and adverse outcomes. There were no significant between-group differences in the incidence of endpoints after a year. However, the number of cardiovascular deaths within a year after CABG was significantly higher among frail patients (2 (1.3%) deaths among patients without frailty, 3 (5.2%) deaths among patients with prefrailty and 7 (3.8%) deaths among patients with frailty, p=0.041, OR 1.4, CI 95%, 1.2—2.2). Conclusion. Frailty is a predictor of adverse outcomes in patients with CAD undergoing myocardial revascularization in early and long-term follow-up period.
No takes yet. Share an insight, caveat, or question.
Кривошапова et al. (2024) conducted a cohort in Coronary artery disease (n=387). Frailty vs. No frailty was evaluated on Cardiovascular death within a year after CABG (OR 1.4, 95% CI 1.2-2.2, p=0.041). Frailty was associated with a higher rate of cardiovascular death within one year after CABG compared to patients without frailty (3.8% vs 1.3%; OR 1.4; 95% CI 1.2-2.2; p=0.041).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: